Literature DB >> 18806305

Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice.

Hamendra Singh Parmar1, Anand Kar.   

Abstract

An investigation on the effects of four different concentrations of peel extract from Citrus sinensis (CS) or Punica granatum (PG) in male mice revealed the maximum glucose lowering and antiperoxidative activities at 25 mg/kg of CS and 200 mg/kg of PG. In a separate experiment their potential was evaluated with respect to the regulation of alloxan induced diabetes mellitus. While a single dose of alloxan (120 mg/kg) increased the serum levels of glucose and alpha-amylase activity, rate of water consumption and lipid peroxidation (LPO) in hepatic, cardiac and renal tissues with a parallel decrease in serum insulin level, administration of 25 mg/kg of CS or 200 mg/kg of PG was found to normalize all the adverse changes induced by alloxan, revealing the antidiabetic and anti peroxidative potential of test fruit peel extracts. Subsequent phytochemical analysis indicated that the high content of total polyphenols in the test peels might be related to the antidiabetic and antiperoxidative effects of the test peels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18806305     DOI: 10.1002/biof.5520310102

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  17 in total

1.  Identification of Enzyme Inhibitors Using Therapeutic Target Protein - Magnetic Nanoparticle Conjugates.

Authors:  Lin-Sen Qing; Nan Tang; Ying Xue; Jian Liang; Yi-Ming Liu; Xun Liao
Journal:  Anal Methods       Date:  2012-04-30       Impact factor: 2.896

2.  Protective role of three vegetable peels in alloxan induced diabetes mellitus in male mice.

Authors:  Yamini Dixit; Anand Kar
Journal:  Plant Foods Hum Nutr       Date:  2010-09       Impact factor: 3.921

3.  Phytochemical Analysis, α-Glucosidase and α-Amylase Inhibitory Activities and Acute Toxicity Studies of Extracts from Pomegranate (Punica granatum) Bark, a Valuable Agro-Industrial By-Product.

Authors:  Nassima Laaraj; Mohamed Bouhrim; Loubna Kharchoufa; Salima Tiji; Hasnae Bendaha; Mohamed Addi; Samantha Drouet; Christophe Hano; Jose Manuel Lorenzo; Mohamed Bnouham; Mostafa Mimouni
Journal:  Foods       Date:  2022-05-06

4.  A pharmacological appraisal of medicinal plants with antidiabetic potential.

Authors:  Vasim Khan; Abul Kalam Najmi; Mohd Akhtar; Mohd Aqil; Mohd Mujeeb; K K Pillai
Journal:  J Pharm Bioallied Sci       Date:  2012-01

5.  Evaluation of antidiabetic, hypolipedimic and antioxidant activity of hydroalcoholic extract of leaves and fruit peel of Punica granatum in male Wistar albino rats.

Authors:  Kartik J Salwe; Devender O Sachdev; Yogesh Bahurupi; Manimekalai Kumarappan
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun

6.  Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells.

Authors:  Linlin Chang; Sheng Jia; Yingying Fu; Tianyi Zhou; Ji Cao; Qiaojun He; Bo Yang; Xian Li; Chongde Sun; Dan Su; Hong Zhu; Kunsong Chen
Journal:  Chin Med       Date:  2015-06-27       Impact factor: 5.455

7.  Antiangiogenic and antiproliferative effects of black pomegranate peel extract on melanoma cell line.

Authors:  N Dana; Sh Haghjooy Javanmard; L Rafiee
Journal:  Res Pharm Sci       Date:  2015 Mar-Apr

8.  Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents.

Authors:  Monica Viladomiu; Raquel Hontecillas; Pinyi Lu; Josep Bassaganya-Riera
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-30       Impact factor: 2.629

9.  Pomegranate peel attenuates hyperglycemic effects of alloxan-induced diabetic rats.

Authors:  Sushil Kumar Middha; Talambedu Usha; Veena Pande
Journal:  EXCLI J       Date:  2014-03-03       Impact factor: 4.068

10.  A Review on Antihyperglycemic and Antihepatoprotective Activity of Eco-Friendly Punica granatum Peel Waste.

Authors:  Sushil Kumar Middha; Talambedu Usha; Veena Pande
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.